Edoxaban Impurity 170 | CAS 2952824-27-8 - Request Quote
Edoxaban Impurity 170
| SZ CAT No: | SZ-E041216 |
| CAS No | 2952824-27-8 |
| Mol.F. | C7H13NO3 |
| Mol.Wt. | 159.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 2952824-28-9 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 170 is chemically (1S,3R,4R)-3-Amino-4-hydroxycyclohexane-1-carboxylic acid. Edoxaban Impurity 170 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 170 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2952824-27-8
Purchase 2952824-27-8
Order 2952824-27-8
Enquire 2952824-27-8
price of 2952824-27-8
2952824-27-8 Supplier
2952824-27-8 Manufacturer
2952824-27-8 Exporter
buy high quality Edoxaban Impurity 170
Purchase Edoxaban Impurity 170
Edoxaban Impurity 170 suppliers
Edoxaban Impurity 170 manufacturers
Edoxaban Impurity 170 price
Order Edoxaban Impurity 170
Enquire Edoxaban Impurity 170
Edoxaban Impurity 170 cost
Edoxaban Impurity 170 Supplier
Edoxaban Impurity 170 Distributor
Edoxaban Impurity 170 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 170 for ANDA Filing
Edoxaban Impurity 170 for Forced Degradation Studies
Edoxaban Impurity 170 Identification Standards
Edoxaban Impurity 170 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


